Summer Sale
50% off Premium Yearly
Opinions Jim Cramer - Mad Money
AirbnbABNBCOMMENTAug 23, 2021
Jim Cramer - Mad MoneyStock price when the opinion was issued
As of Jun 18, 2026. Market Open.
You might be interested:
Their conference call revealed stickiness in supply and are starting to see demand weakness.
Joe Terranova
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium contentTrue, every company used Collision as a platform to shill their services, but as Branch stressed, building trust is “foundational” for Airbnb. If hosts and guests don't trust each other, then the entire platform collapses. In the first half of 2023, the platform has been performing well. In early May, the company announced it expected fewer bookings in Q2 2023 vs. the previous year. The outlook is part the entire travel sector returning to pre-Covid travel patterns even as inflation remains high and fears of a recession hang in the air. In Q1, Airbnb's gross booking value rose 19% to $20.4 billion in line with a 19% climb in nights and experiences booked to 121 million. Airbnb also faces competition from Booking.com and Vrbo. Personally, I've used all three and consider them good, though I prefer Airbnb's system because I can directly message a host. Plus, their system encourages user reviews.
Premium contentOur PAST TOP PICK with ABNB has triggered its stop at $105. To remain disciplined we recommend covering the position at this time. This will result in a net investment gain of 22%, when combined with our previous buy recommendations.
In 2022, Airbnb helped travelers book 393.7 million nights until gross bookings hit $63.2 billion that year, with revenues of $8.4 billion. That marked Airbnb’s first-ever profit (of $2 billion). Remember that the company lost $674 million in 2019. Read Silver linings in the SVB fall-out for our full analysis.
Premium contentPremium contentPremium content
Last week, the company cautioned the market about travel given the Delta variant, so the stock got slammed. Today, the stock jumped 2% on the FDA-Pfizer approval.